Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Breast Cancer

  Free Subscription

Articles published in Cancer Cell

Retrieve available abstracts of 24 articles:
HTML format

Single Articles

    September 2020
  1. PUSZTAI L, Taylor R, Mougalian SS
    Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer.
    Cancer Cell. 2020;38:323-325.
    PubMed     Abstract available

    August 2020
  2. ARRUABARRENA-ARISTORENA A, Maag JLV, Kittane S, Cai Y, et al
    FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
    Cancer Cell. 2020 Aug 25. pii: S1535-6108(20)30414.
    PubMed     Abstract available

    July 2020
  3. SIERSBAEK R, Scabia V, Nagarajan S, Chernukhin I, et al
    IL6/STAT3 Signaling Hijacks Estrogen Receptor alpha Enhancers to Drive Breast Cancer Metastasis.
    Cancer Cell. 2020 Jul 6. pii: S1535-6108(20)30311.
    PubMed     Abstract available

    May 2020
  4. SAVAS P, Loi S
    Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2020;37:623-624.
    PubMed     Abstract available

    April 2020
  5. HANKER AB, Sudhan DR, Arteaga CL
    Overcoming Endocrine Resistance in Breast Cancer.
    Cancer Cell. 2020;37:496-513.
    PubMed     Abstract available

    February 2020
  6. ZHENG ZY, Anurag M, Lei JT, Cao J, et al
    Neurofibromin Is an Estrogen Receptor-alpha Transcriptional Co-repressor in Breast Cancer.
    Cancer Cell. 2020 Feb 25. pii: S1535-6108(20)30092.
    PubMed     Abstract available

  7. SUDHAN DR, Guerrero-Zotano A, Won H, Gonzalez Ericsson P, et al
    Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers.
    Cancer Cell. 2020;37:183-199.
    PubMed     Abstract available

    November 2019
  8. HOPKINS JL, Zou L
    Induction of BRCAness in Triple-Negative Breast Cancer by a CDK12/13 Inhibitor Improves Chemotherapy.
    Cancer Cell. 2019;36:461-463.
    PubMed     Abstract available

    October 2019
  9. QUEREDA V, Bayle S, Vena F, Frydman SM, et al
    Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer.
    Cancer Cell. 2019 Oct 8. pii: S1535-6108(19)30424.
    PubMed     Abstract available

    April 2019
  10. BRONTE V
    Deciphering Macrophage and Monocyte Code to Stratify Human Breast Cancer Patients.
    Cancer Cell. 2019;35:538-539.
    PubMed     Abstract available

    January 2019
  11. ISHAY-RONEN D, Diepenbruck M, Kalathur RKR, Sugiyama N, et al
    Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.
    Cancer Cell. 2019;35:17-32.
    PubMed     Abstract available

  12. HINZ S, LaBarge MA
    Hijacking EMT: Better Fat Than Dead.
    Cancer Cell. 2019;35:1-2.
    PubMed     Abstract available

    December 2018
  13. SHEN M, Jiang YZ, Wei Y, Ell B, et al
    Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
    Cancer Cell. 2018 Dec 10. pii: S1535-6108(18)30537.
    PubMed     Abstract available

    May 2018
  14. CANOVAS B, Igea A, Sartori AA, Gomis RR, et al
    Targeting p38alpha Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.
    Cancer Cell. 2018 May 14. pii: S1535-6108(18)30181.
    PubMed     Abstract available

    March 2018
  15. LI L, Liang Y, Kang L, Liu Y, et al
    Transcriptional Regulation of the Warburg Effect in Cancer by SIX1.
    Cancer Cell. 2018;33:368-385.
    PubMed     Abstract available

    February 2018
  16. LI CW, Lim SO, Chung EM, Kim YS, et al
    Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.
    Cancer Cell. 2018;33:187-201.
    PubMed     Abstract available

  17. SALATINO M, Girotti MR, Rabinovich GA
    Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2018;33:155-157.
    PubMed     Abstract available

  18. MCDONNELL DP, Norris JD, Chang CY
    Neomorphic ERalpha Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug Discovery.
    Cancer Cell. 2018;33:153-155.
    PubMed     Abstract available

  19. COSTA A, Kieffer Y, Scholer-Dahirel A, Pelon F, et al
    Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
    Cancer Cell. 2018 Feb 12. pii: S1535-6108(18)30011.
    PubMed     Abstract available

  20. JESELSOHN R, Bergholz JS, Pun M, Cornwell M, et al
    Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.
    Cancer Cell. 2018;33:173-186.
    PubMed     Abstract available

    January 2018
  21. DE MINGO PULIDO A, Gardner A, Hiebler S, Soliman H, et al
    TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.
    Cancer Cell. 2018;33:60-74.
    PubMed     Abstract available

    November 2017
  22. PALAZON A, Tyrakis PA, Macias D, Velica P, et al
    An HIF-1alpha/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
    Cancer Cell. 2017;32:669-683.
    PubMed     Abstract available

    October 2017
  23. GULLUNI F, Martini M, De Santis MC, Campa CC, et al
    Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2alpha Scaffolding Function.
    Cancer Cell. 2017;32:444-459.
    PubMed     Abstract available

  24. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.